University Clinic Bonn
Welcome,         Profile    Billing    Logout  
 1 Trial 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Schütz, Christian G
CAPU RISE, NCT05261321: Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure

Recruiting
1
20
Canada
Cannabis oil with a high ratio of THC to CBD, Cannabis oil with a high ratio of CBD to THC, Placebo
University of British Columbia
Healthy
12/24
12/24
Skowasch, Dirk
NCT05243680 / 2020-004334-38: An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Active, not recruiting
3
641
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
05/25
05/25
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
NCT06178341: Effects of the Kata® Inhalations-App on Inhaler Handling Errors, Adherence, and Asthma Control in Patients with Asthma.

Active, not recruiting
N/A
200
Europe
Kata Inhalations-App
VisionHealth GmbH, Thoraxklinik-Heidelberg gGmbH
Asthma
01/25
01/25
NCT06035289: Register Schweres Asthma - German Asthma Net e.V.

Recruiting
N/A
4500
Europe
German Asthma Net e.V., AstraZeneca, GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A.
Severe Asthma
11/26
11/26
Winkler, Jürgen
LIPCAL-ALS II, NCT06280079: Ultra-high-caloric, Fatty Diet in ALS

Recruiting
N/A
392
Europe
Ultra-high-caloric fatty diet, Placebo
University of Ulm
Amyotrophic Lateral Sclerosis
06/27
06/27
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Recruiting
N/A
2000
Europe
Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)
Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)
Hereditary Spastic Paraplegia
08/39
08/41
NCT01574053: Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Recruiting
N/A
35000
Europe, Canada, US, RoW
CHDI Foundation, Inc.
Huntington's Disease
01/62
01/62
Weydt, Patrick
COURAGE-ALS, NCT04944784 / 2020-004040-29: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Terminated
3
489
Europe, Canada, US, RoW
Reldesemtiv, Placebo
Cytokinetics
Amyotrophic Lateral Sclerosis
07/23
07/23
NCT05039099 / 2020-005971-11: A Study to Evaluate, Safety, Tolerability, Pharmacodynamic (PD) Markers and Pharmacokinetics (PK) of AP-101 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Active, not recruiting
2
63
Europe, Canada, US, RoW
AP-101, Placebo
AL-S Pharma, AL-S Pharma
Amyotrophic Lateral Sclerosis
12/24
10/25
NfL-ALS, NCT06201650: Neurofilament Light Chain in Amyotrophic Lateral Sclerosis

Recruiting
N/A
3000
Europe
Neurofilament light chain
Charite University, Berlin, Germany, Boris Canessa ALS Stiftung
Amyotrophic Lateral Sclerosis, Motor Neuron Disease
12/24
12/24
LIPCAL-ALS II, NCT06280079: Ultra-high-caloric, Fatty Diet in ALS

Recruiting
N/A
392
Europe
Ultra-high-caloric fatty diet, Placebo
University of Ulm
Amyotrophic Lateral Sclerosis
06/27
06/27

Download Options